GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?
Inkster, Becky
GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders? [electronic resource] - Translational psychiatry 10 2018 - 216 p. digital
Publication Type: Journal Article; Review
2158-3188
10.1038/s41398-018-0270-z doi
Animals
Cognition--drug effects
Erythropoietin--administration & dosage
Glycogen Synthase Kinase 3 beta--metabolism
Hippocampus--drug effects
Humans
Mood Disorders--drug therapy
Neuroprotective Agents--administration & dosage
GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders? [electronic resource] - Translational psychiatry 10 2018 - 216 p. digital
Publication Type: Journal Article; Review
2158-3188
10.1038/s41398-018-0270-z doi
Animals
Cognition--drug effects
Erythropoietin--administration & dosage
Glycogen Synthase Kinase 3 beta--metabolism
Hippocampus--drug effects
Humans
Mood Disorders--drug therapy
Neuroprotective Agents--administration & dosage